Clínica de Marly S.A. (BVC:MARLY)

Clínica de Marly Income Statement

Financials in millions COP. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	428,687	413,169	362,905	321,343	278,599	209,776
Revenue Growth (YoY)	11.68%	13.85%	12.93%	15.34%	32.81%	-15.90%
Cost of Revenue	265,826	256,982	231,992	208,407	178,364	144,716
Gross Profit	162,861	156,187	130,913	112,935	100,234	65,060
Selling, General & Admin	42,141	40,774	36,964	33,870	28,018	26,881
Other Operating Expenses	6,545	5,608	5,453	3,985	3,091	2,401
Operating Expenses	54,554	52,087	47,948	43,641	36,557	35,008
Operating Income	108,307	104,100	82,965	69,294	63,678	30,052
Interest Expense	-794.46	-1,364	-2,324	-2,206	-1,608	-2,605
Interest & Investment Income	18,474	16,025	12,491	5,805	1,749	3,697
Earnings From Equity Investments	36,628	36,628	21,135	19,381	18,419	4,091
Currency Exchange Gain (Loss)	-517.01	2,345	-3,530	2,616	2,421	133.45
Other Non Operating Income (Expenses)	-21,657	-21,831	-8,019	-12,403	-12,456	5,858
EBT Excluding Unusual Items	140,440	135,903	102,718	82,487	72,203	41,227
Gain (Loss) on Sale of Investments	253.5	233.45	-	-	-	-
Gain (Loss) on Sale of Assets	-	-	-	-	26.91	23.36
Asset Writedown	-9,384	-8,460	-7,413	-550.3	-1,958	-1,134
Pretax Income	131,309	127,676	95,306	81,936	70,271	40,117
Income Tax Expense	40,809	38,820	30,536	26,642	20,467	12,280
Earnings From Continuing Operations	90,501	88,856	64,770	55,295	49,804	27,836
Minority Interest in Earnings	-848.81	-1,121	-89.46	-713.74	-830.06	-385.4
Net Income	89,652	87,735	64,681	54,581	48,974	27,451
Net Income to Common	89,652	87,735	64,681	54,581	48,974	27,451
Net Income Growth	22.88%	35.64%	18.50%	11.45%	78.41%	-26.87%
Shares Outstanding (Basic)	-	-	11	11	11	11
Shares Outstanding (Diluted)	-	-	11	11	11	11
EPS (Basic)	-	-	6057.41	5111.57	4586.50	2570.82
EPS (Diluted)	-	-	6057.41	5111.57	4586.50	2570.82
EPS Growth	-	-	18.50%	11.45%	78.41%	-26.87%
Free Cash Flow	27,294	-422.9	23,300	27,495	16,504	22,531
Free Cash Flow Per Share	-	-	2182.04	2574.90	1545.65	2110.04
Dividend Per Share	1596.000	1596.000	1200.000	696.000	564.000	-
Dividend Growth	33.00%	33.00%	72.41%	23.40%	-	-
Gross Margin	37.99%	37.80%	36.07%	35.14%	35.98%	31.01%
Operating Margin	25.26%	25.20%	22.86%	21.56%	22.86%	14.33%
Profit Margin	20.91%	21.23%	17.82%	16.98%	17.58%	13.09%
Free Cash Flow Margin	6.37%	-0.10%	6.42%	8.56%	5.92%	10.74%
EBITDA	114,106	109,736	88,446	75,033	69,075	35,727
EBITDA Margin	26.62%	26.56%	24.37%	23.35%	24.79%	17.03%
D&A For EBITDA	5,799	5,635	5,480	5,739	5,397	5,674
EBIT	108,307	104,100	82,965	69,294	63,678	30,052
EBIT Margin	25.26%	25.20%	22.86%	21.56%	22.86%	14.33%
Effective Tax Rate	31.08%	30.40%	32.04%	32.52%	29.13%	30.61%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.